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1. Introduction 
It has recently been foundby Kedinger et al. [l] , 
Seifart [2], Jacob et al. [3] and Novello et al. [4] 
that mammalian RNA polymerase is inhibited by 
cr-amanitin, a toxic peptide isolated from Amanira 
phalloides, whereas E. coli RNA polymerase is insen- 
sitive to this drug. On the other hand, the reverse 
situation occurs in the presence of rifampicin [5,6] . 
To establish further that structural differences in 
RNA polymerase of prokaryotic and eukaryotic cells 
exist, we have studied the effect of these drugs on 
RNA polymerase isolated from yeast. In the present 
work, it is shown that yeast RNA polymerase is insen- 
sitive to rifampicin, but completely inhibited by 
a-amanitin, although the amount of toxic peptide re- 
quired is rather high. 
Yeast RNA polymerase purified according to 
Frederick et al. [7], required denatured DNA as 
template and Mn2+ ions as reported by these authors. 
Its specific activity was 400 nmoles of 3H-UMP 
incorporated per hr per mg protein E. coli RNA poly- 
merase and Y-~~P-GTP were prepared as previously 
described [8,9]. 
2. Results and discussion 
2.1. Influence of rifampicin and cw-amanitin o  RNA 
synthesis by yeast and E. coli RNA polymerase 
Fig. 1 shows that yeast enzyme is unaffected by 
amounts of rifampicin hundred times higher than 
those required to inhibit to 80 percent the E. coli 
enzyme. 
In contrast, as shown in fig. 2, yeast enzyme can be 
220 
completely inhibited by cu-amanitin, whereas the 
E. coli RNA polymerase is virtually unaffected by the 
highest concentration used. 
Assuming that our yeast enzyme preparation is 
25 percent pure as inferred from gel electrophoresis, 
and that its molecular weight is of the order of 
500,000 daltons, it appears that complete inhibition 
requires a ratio of about 500 amanitin molecules per 
molecule of RNA polymerase, which is two orders of 
magnitude higher than the amount required to 
inhibit the mammalian enzyme [ 1,2] . This crude 
calculation indicates that although yeast RNA poly- 
merase behaves, on the whole, like mammalian RNA 
polymerase, there are definite differences between 
RNA polymerases from various eukaryotic cells. 
2.2. Influence of a-amanitin on chain initiation and 
elongation 
The mode of action of a-amanitin on mammalian 
RNA polymerase is still unknown. There is evidence 
that the toxic peptide interferes with the elongation of 
RNA chains [l-4]. It was of interest to investigate 
its effects on chain initiation and elongation by yeast 
RNA polymerase. This enzyme, like E. coli RNA 
polymerase, initiates with purine nucleoside triphos- 
phates, and GTP chains are predominant using 
denatured calf thymus DNA as template [7] . Fig. 3 
shows that, although the initiation of chains, as ex- 
pressed by T-~~P-GTP incorporation, is less affected 
than total RNA synthesis, most of the inhibition can 
be accounted for by a decrease in the number of 
chains initiated. In this experiment, a-amanitin was 
added before the beginning of the reaction. The 
kinetics in fig. 4 show that yeast RNA polymerase, in 
North-HoIland Publishing Company - Amsterdam 
Volume 7, number 3 FEBS LETTERS April 1970 
100 b-+-____ 
f !I 1 ----mm__ 0 -------___~_ E. cd rnwm= I 
VJ 
I I 
0 1 
a-AMiNiTiN ( pg,25u pl)” 
Fig. 1. Resistance of yeast RNA polymerase to rifampicin. The 
assay mixtures (0.25 ml) contained heat-denatured calf 
thymus DNA 23 &ml, 70 mM tris-HCl buffer pH 7.75, 
13 mM p-mercaptoethanol, 4 mM MnCl*, 1 mM CTP, ATP, 
GTP, 0.2 mM sH-UTP (1700 cpm/mmoIe), yeast RNA poly- 
merase 80 pg/ml and rifampicin as indicated in the figure. 
Incubation was carried out for 10 min at 37’ and the RNA 
recovered by acid precipitation with 5 percent TCA and 
counted. E. colz’ RNA polymerase (20 pg/ml) was assayed as 
already described [8] with 13 pg/ml of native calf thymus 
DNA and nucleoside triphosphates as in the yeast enzyme 
assay. The results are expressed in percent of ‘H-UMP in- 
corporation in the absence of rifampicin which was 1.3 
nmoles/lO min in both cases. 
Fig. 2. Inhibition of yeast RNA polymerase by cw-amanitin. 
RNA synthesis by yeast and E. coli RNA polymerase was 
assayed as described in the legend to fig. 1 except that & 
amanitin was added in place of rifampicin. 
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Fig. 3. Effect of (Y-amanitin on RNA chain initiation and 
elongation. RNA synthesis by yeast RNA polymerase was as 
sayed as described in fig. 1, except that 0.13 mMr-32P-GTP 
(500 cpm/pmole) replaced non-radioactive GTP. RNA poly- 
merase and eamanitin were mixed and the reaction started by 
the addition of the nucleoside triphosphates and DNA. RNA 
was recovered by acid precipitation. Incorporation in the 
absence of inhibitor was 0.75 nmole 3H-UMP and 5 pmoles 
y-32~~~~ in 30 min. 
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Fig. 4. Kinetics of RNA chain initiation and elongation by 
yeast RNA polymerase. Effect of the addition of eamanitin 
at different times. Assay mixture, scaled up to 3 ml, was as 
described in fig. 3,except for yeast enzyme (160 rg/ml) and 
DNA (34 fig/ml). Aliquots were taken at the time indicated 
by the arrows, eamanitin (32 pg/mI) added and further in- 
cubated. The incorporation of 3H-UMP and T-~~P-GTP, was 
measured on 100 pl aliquots at different times. 
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absence of cw-amanitin, initiates throughout the 
60 min of the incubation. In this respect the yeast 
enzyme also behaves like E. coli RNA polymerase 
which can repeatedly initiate on single stranded DNA. 
If cY-amanitin is introduced while RNA synthesis is 
under way, 3H-UMP incorporation is stopped im- 
mediately and chain reinitiation is almost completely 
blocked. Thus, as in the case of mammalian enzyme, 
o-amanitin inhibits chain propagation, possibly by 
interfering with the formation of the phosphodiester 
bond. As a consequence, when added before initiation, 
the peptide may prevent the formation of the first 
phosphodiester bonds, thus inhibiting Y-~~P-GTP 
incorporation. Up to now, we found no toxicity of 
a-amanitin toward growing yeast cells, but it is not 
known whether the drug can enter the cells. 
A general feature of the mammalian RNA poly- 
merases isolated so far seems to be their high efficiency 
on denatured templates [2, 6, lo] . Our preparation of 
yeast RNA polymerase is an extreme example of this 
situation as it is completely unable to use native DNA 
as template. It could be an incomplete or damaged 
enzyme, unable to carry out chain initiation on 
doubled stranded templates. The addition of the 
E. coli initiation factor, u, [ 11,8] does not stimulate 
the yeast enzyme with T4 DNA as template. In fact 
yeast RNA polymerase does not synthesize RNA on 
native calf thymus DNA. However this DNA is a good 
template for the basic E. cd enzyme devoid of u 
factor [ 1 l] . It is thus probable that the binding and 
initiation processes are quite different in these two 
in vitro systems. 
Note added in proof 
While this paper was written the work of Winters- 
berger and Wintersberger (FEBS Letters, 6 (1970) 
58), came to our attention showing the insensitivity 
of RNA synthesis in yeast to rifampicin which is con- 
firmed by the results presented in fig. 1 of this paper. 
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